JPRN-jRCT1080223122已完成Unknown
Drug use surveillance of Takecab tablets for Gastric ulcer, duodenal ulcer, and reflux esophagitis
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 3,183
研究概览
简要总结
In conclusion, from the results stated above, this surveillance raised no new concerns about the safety or efficacy of Takecab Tablets in participants with gastric ulcer, duodenal ulcer, or reflux esophagitis. Please refer to conclusions of "Adverse Events" and "Secondary Outcome Measures" sections for the details.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants with gastric ulcer, duodenal ulcer, and reflux esophagitis
排除标准
- •- Participants with previous history of hypersensitivity to ingredients in Takecab tablets
- •- Participants taking atazanavir sulfate or rilpivirine hydrochloride
- •- Participants meeting the criteria of scarring stage (S1, S2) of endoscopic classification defined by Sakita and Miwa at the start of the treatment with Takecab tablets, in the case that the target disease is gastric ulcer or duodenal ulcer
- •- Participants meeting the criteria of Grade N or Grade M of Los Angeles classification (Hoshihara's modification) at the start of the treatment with Takecab tablets, in the case that the target disease is reflux esophagitis.
研究者
相似试验
已完成
Unknown
Special Drug Use Surveillance of Vonoprazan for Maintenance Therapy of Reflux Esophagitis: Long-term UseJPRN-jRCT1080223147Takeda Pharmaceutical Company Limited1,237
已完成
Unknown
Special drug use surveillance of Vonoprazan for prevention of recurrence of gastric/duodenal ulcer in patients receiving low-dose aspirin: long-term useGastric or duodenal ulcersJPRN-jRCT1080223380Takeda Pharmaceutical Company Limited1,119
未知
Unknown
Drug use surveillance of Takecab for Supplement to Helicobacter pylori eradicatioThe following diseases in patients for whom H. pylori will be eradicated with triple therapy: Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, stomach following endoscopic treatment of early gastric cancer, or H. pylori gastritisJPRN-jRCT1080222951TAKEDA PHARMACEUTICAL COMPANY LTD.500
已完成
Unknown
Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Type 2 Diabetes Mellitus Patients with severe renal impairment or end-stage renal diseaseJPRN-jRCT1080225091Takeda Pharmaceutical Company Limited83
已完成
Unknown
Special drug use surveillance of Vonoprazan for prevention of recurrence of gastric/duodenal ulcer in patients receiving non-steroidal anti-inflammatory drugs: long-term useA History of Gastric or Duodenal UlcersJPRN-jRCT1080223381Takeda Pharmaceutical Company Limited1,304